Clinical Significance of Epigenetic Silencing of ARNTL and DCC in Ovarian Cancer

碩士 === 國立中正大學 === 分子生物研究所 === 101 === Ovarian cancer is the fifth leading cause of cancer death and the most deadly gynecological malignancies in women. Epigenetic modifications play an important role in regulating gene transcription. Specifically, aberrant promoter hypermethylation has been implica...

Full description

Bibliographic Details
Main Authors: Ting-Chuan Zeng, 曾梃銓
Other Authors: Michael Wing-Yan Chan
Format: Others
Language:en_US
Published: 2013
Online Access:http://ndltd.ncl.edu.tw/handle/95233748945984566759
id ndltd-TW-101CCU00061014
record_format oai_dc
spelling ndltd-TW-101CCU000610142015-10-13T22:24:05Z http://ndltd.ncl.edu.tw/handle/95233748945984566759 Clinical Significance of Epigenetic Silencing of ARNTL and DCC in Ovarian Cancer ARNTL和DCC在卵巢癌表基因默化的臨床意義 Ting-Chuan Zeng 曾梃銓 碩士 國立中正大學 分子生物研究所 101 Ovarian cancer is the fifth leading cause of cancer death and the most deadly gynecological malignancies in women. Epigenetic modifications play an important role in regulating gene transcription. Specifically, aberrant promoter hypermethylation has been implicated as a hallmark of cancer. In order to identify genes that are differentially methylated in ovarian cancer, we performed differential methylation hybridization (DMH) in various ovarian cancer cell lines using Agilent 244K CpG island microarray. One of the targets, ARNTL which is a core component of the circadian clock is methylated in a sub-set of ovarian cancer cell lines. COBRA assay and epigenetic treatment confirmed the results of the microarray. ChIP-PCR revealed that histone modifications trimethyl-H3K4 in IOSE and trimethyl-H3K27 is enriched in MCP3 ovarian cancer cells. Overexpression of ARNTL restored the rhythmic activity of c-myc in ovarian cancer cells. Further functional analysis demonstrated that over-expression of ARNTL inhibited cell growth and enhanced chemosensitivity to cisplatin. These results suggested that ARNTL may be a tumor suppressor and is epigenetically silenced in ovarian cancer. Additionally, we have investigated the promoter methylation of DCC by methylation specific PCR (MSP) in 4 normal ovary, 8 benign and 55 ovarian cancer patient samples. Except for normal ovary and benign tumor, methylation of DCC was detected in 55% of the cancer patients. Kaplan meier survival analysis also found that patient samples with DCC methylation have significantly shorter survival. In conclusion, ARNTL and DCC are epigenetically silenced in ovarian cancer. The diagnostic potential of the methylation of ARNTL and DCC deserves further investigation. Michael Wing-Yan Chan 陳永恩 2013 學位論文 ; thesis 60 en_US
collection NDLTD
language en_US
format Others
sources NDLTD
description 碩士 === 國立中正大學 === 分子生物研究所 === 101 === Ovarian cancer is the fifth leading cause of cancer death and the most deadly gynecological malignancies in women. Epigenetic modifications play an important role in regulating gene transcription. Specifically, aberrant promoter hypermethylation has been implicated as a hallmark of cancer. In order to identify genes that are differentially methylated in ovarian cancer, we performed differential methylation hybridization (DMH) in various ovarian cancer cell lines using Agilent 244K CpG island microarray. One of the targets, ARNTL which is a core component of the circadian clock is methylated in a sub-set of ovarian cancer cell lines. COBRA assay and epigenetic treatment confirmed the results of the microarray. ChIP-PCR revealed that histone modifications trimethyl-H3K4 in IOSE and trimethyl-H3K27 is enriched in MCP3 ovarian cancer cells. Overexpression of ARNTL restored the rhythmic activity of c-myc in ovarian cancer cells. Further functional analysis demonstrated that over-expression of ARNTL inhibited cell growth and enhanced chemosensitivity to cisplatin. These results suggested that ARNTL may be a tumor suppressor and is epigenetically silenced in ovarian cancer. Additionally, we have investigated the promoter methylation of DCC by methylation specific PCR (MSP) in 4 normal ovary, 8 benign and 55 ovarian cancer patient samples. Except for normal ovary and benign tumor, methylation of DCC was detected in 55% of the cancer patients. Kaplan meier survival analysis also found that patient samples with DCC methylation have significantly shorter survival. In conclusion, ARNTL and DCC are epigenetically silenced in ovarian cancer. The diagnostic potential of the methylation of ARNTL and DCC deserves further investigation.
author2 Michael Wing-Yan Chan
author_facet Michael Wing-Yan Chan
Ting-Chuan Zeng
曾梃銓
author Ting-Chuan Zeng
曾梃銓
spellingShingle Ting-Chuan Zeng
曾梃銓
Clinical Significance of Epigenetic Silencing of ARNTL and DCC in Ovarian Cancer
author_sort Ting-Chuan Zeng
title Clinical Significance of Epigenetic Silencing of ARNTL and DCC in Ovarian Cancer
title_short Clinical Significance of Epigenetic Silencing of ARNTL and DCC in Ovarian Cancer
title_full Clinical Significance of Epigenetic Silencing of ARNTL and DCC in Ovarian Cancer
title_fullStr Clinical Significance of Epigenetic Silencing of ARNTL and DCC in Ovarian Cancer
title_full_unstemmed Clinical Significance of Epigenetic Silencing of ARNTL and DCC in Ovarian Cancer
title_sort clinical significance of epigenetic silencing of arntl and dcc in ovarian cancer
publishDate 2013
url http://ndltd.ncl.edu.tw/handle/95233748945984566759
work_keys_str_mv AT tingchuanzeng clinicalsignificanceofepigeneticsilencingofarntlanddccinovariancancer
AT céngtǐngquán clinicalsignificanceofepigeneticsilencingofarntlanddccinovariancancer
AT tingchuanzeng arntlhédcczàiluǎncháoáibiǎojīyīnmòhuàdelínchuángyìyì
AT céngtǐngquán arntlhédcczàiluǎncháoáibiǎojīyīnmòhuàdelínchuángyìyì
_version_ 1718075401136242688